Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029899

SVP, COO & CFO sold 17,448 shares at $3.95 ($68,920)

  • SVP, COO & CFO acquired 28,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Labrucherie Gil M · SVP, COO & CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-15 Grant or award : show line 1 in the form +28,750 330,353 D
2022-05-16 Sale : show line 2 in the form −17,448 $3.95 $68,920 312,905 D
Open-market sales · 17,448 sh · avg $3.95 · $68,920
Loading xslF345X03/doc4.xml…